Hydrochlorothiazide and high-fat diets reduce plasma magnesium levels and increase hepatic oxidative stress in rats

Magnesium Research

Volumn 26, Issue 1, 2013, Pages 32-40

  Ribeiro, Marinei Cristina Pereira ^a   de Ávila, Daiana Silva ^b   de Vargas Barbosa, Nilda Berenice ^a   Meinerz, Daiane Francine ^a   Waczuk, Emily Pansera ^b   Hassan, Waseem ^c   Rocha, João Batista Teixeira ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^c UNIVERSITY OF PESHAWAR   (Pakistan)

Author keywords

High fat diet; Hydrochlorothiazide; Hyperglycemia; Magnesium; Oxidative stress

Indexed keywords

ASCORBIC ACID; FRUCTOSAMINE; HYDROCHLOROTHIAZIDE; POTASSIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; LIPID DIET; LIPID PEROXIDATION; LIVER; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; WEIGHT GAIN;

EID: 84984532240     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2013.0334     Document Type: Article

References (41)

1. George JD, Price CJ, Tyl RW, Marr MC, Kimmerl CA. The evaluation of the developmental toxicity of hydrochlorothiazide in mice and rats. Fundam Appl Toxicol 1995; 26:174-180.
2. Grossman E, Messerli FH. Long-term safety of antihypertensive therapy. Prog Cardiovasc Dis 2006; 49:16-25.
3. Messerli FH, Bangalore S. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med 2011; 124:896-899.
4. Dinicolantonio JJ. Hydrochlorothiazide: is it a wise choice? Expert Opin Pharmacother 2012; in press.
5. Weir MR, Moser M. Diuretics and fj-blockers: Is there a risk for dyslipidemia? Am Heart J 2000; 139:174-184.
6. Zee AM, Turner ST, Schwartz GL, Chapman AB, Klungel OH, Boerwinkle E. Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects. Am JHypertens 2005; 18:1077-1083.
7. Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. High-fat diet induced diabetic cardiomyopathy. Prostaglandins. Leukot Essent Fatty Acids 2011; 85: 219-225.
8. Panchal SK, Brown L. Rodent models for metabolic syndrome research. J Biomed Biotechnol 2011; 2011: 351982.
9. Messier C, Whately K, Liang J, Du L, Puissant D. The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behav Brain Res 2007; 178: 139-145.
10. Folmer V, Soares JCM, Gabriel D, Rocha BTR. A high-fat diet inhibits 8-aminolevulinate dehydratase and increases lipid peroxidation in mice (Mus mus-culus). JNutr 2003; 133: 2165-2170.
11. Han D-H, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997; 46:1761-1767.
12. Rasheed H, Elahi S, Ajaz H. Serum Magnesium and Atherogenic Lipid Fractions in Type II Diabetic Patients of Lahore, Pakistan. Biol Trace Elem Res 2012; in press.
13. Jose B, Jain V, Vikram NK, Agarwala A, Saini S. Serum Magnesium in Overweight Children. Indian Pediatr 2012; 49:109-112.
14. Guerrero-Romero F, Bermudez-Pena C, Rodriguez-Moran M. Severe hypomagnesemia and low-grade inflammation in the metabolic syndrome. Magnesium Res 2011; 24:45-53.
15. Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 2007; 4: 63-71.
16. Brito VB, Folmer V, Soares JCM, Silveira ID, Rocha JBT. Long-term sucrose and glucose consumption decreases the 8-aminolevulinate dehydratase activity in mice. Nutrition 2007; 23:818-826.
17. Maiese K, Chong ZZ, Shang YC, Hou JL. Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus. J Clin Pharmacol 2011; 51:128-152.
18. Maritim AC, Sanders RA, Watkins III JB. Diabetes, oxidative stress, and antioxidants: a review. JBiochem Mol Toxicol 2003; 17: 24-38.
19. Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17: 5240-5245.
20. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30: 620-650.
21. Ohkawa H, Ohishi H, Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
22. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A, Ahn B, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Method Enzymol 1989; 186:464-478.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
24. Jacques-Silva MC, Nogueira CW, Broch LC, Flores EM, Rocha JBT. Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice. Pharmacol Toxicol 2001; 88: 119-25.
25. Ribeiro MC, Barbosa NB, de Almeida TM, Par-cianello LM, Perottoni J, de Avila DS, Rocha JB. High-fat diet and hydrochlorothiazide increase oxidative stress in brain of rats. Cell Biochem Funct 2009; 27: 473-478.
26. Grotto D, Maria LS, Valentini J, Paniz C, Schmitt G, Garcia SC, Pomblum VJ, Rocha JBT, Farina M. Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quimica Nova 2009;32:169-174.
27. Janero DJ. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid perox-idation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-540.
28. Slater TF. Overview of methods used for detecting lipid peroxidation. Methods Enzymol 1984; 105: 283-293.
29. Puntel RL, Roos DH, Grotto D, Garcia SC, Nogueira CW, Rocha JBT. Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: A comparative study using the col-orimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenate. Life Sci 2007; 81: 51-62.
30. Barbosa NBV, Rocha JBT, Soares JCM, Wondracek DC, Gonçalves JF, Schetinger MRC, Nogueira CW. Dietary diphenyl diselenide reduces the STZ-induced toxicity. Food Chem Toxicol 2008;46: 186-194.
31. Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 1980;29: 498-502.
32. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andres R. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983; 32:106-111.
33. Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys 2007; 458: 33-39.
34. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003; 24: 39-52.
35. Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Vascular biology of magnesium and its transporters in hypertension. MagnesRes 2010; 23: S207-S215.
36. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 2004; 61:1569-1576.
37. Lourdes LM, Crua T, Pousada JC, Rodrigues LE, Barbosa K, Canguru V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998; 21: 682-686.
38. Johnson S.The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001; 56: 163-170.
39. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458: 40-47.
40. Rodríguez-Morán M, Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res Rev 2011; 27: 590-596.
41. Barbagalo M, Dominguez LJ, Bardicef O, Resnick LM. Altered cellular magnesium responsiveness to hyperglycemia in hypertensive subjects. Hypertension 2001; 38: 612-615.